Title: Hepatitis C dsRNA Effector Molecules, Expression Constructs, Compositions, and Methods of Use
Patent Number: 8,614,198
Filed: June 28, 2008
Lead Inventor: Daniel McCallus, Alnylam Pharmaceuticals
Title: Double-stranded RNA Director to CASP2 and Methods of Use Thereof
Patent Number: 8,614,309
Filed: Sept. 4, 2008
Lead Inventor: Elena Feinstein, Quark Pharmaceuticals
Title: Devices, Systems, and Methods for Improving Memory and/or Cognitive Function through Brain Delivery of siRNA
Patent Number: 8,618,069
Filed: Oct. 8, 2009
Lead Inventor: William Kaemmerer, Medtronic
Title: RNA Interference-mediated Inhibition of Gene Expression using Chemically Modified Short Interfering Nucleic Acid
Patent Number: 8,618,277
Filed: May 25, 2012
Lead Inventor: Leonid Beigelman, Merck
Title: RNAi-mediated Inhibition of Histamine Receptor H1-related Conditions
Patent Number: 8,618,278
Filed: June 11, 2012
Lead Inventor: John Yanni, Alcon